Targeting transitioning lung monocytes/macrophages as treatment strategies in lung disease related to environmental

Aaron D Schwab1, Todd A Wyatt2,3,4, Grace Moravec1

  • 1Division of Allergy & Immunology, University of Nebraska Medical Center, Omaha, NE, USA.

Respiratory Research
|April 9, 2024
PubMed
Abstract

Insights

Targeting peripheral monocytes can mitigate lung damage from environmental exposures like lipopolysaccharide (LPS). Depleting monocytes reduced inflammatory and fibrotic lung responses, offering a potential therapeutic strategy for lung diseases.

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Environmental Health

Background:

  • Environmental and occupational exposures are major causes of lung disease.
  • Agricultural organic dust extracts (ODE) and lipopolysaccharide (LPS) trigger lung monocyte/macrophage responses, but their exact roles are unclear.

Purpose of the Study:

  • To investigate the cellular roles of recruited monocytes and macrophages in lung inflammation and fibrosis following exposure to ODE and LPS.
  • To evaluate the therapeutic potential of targeting peripheral monocytes to reduce lung injury.

Main Methods:

  • Utilized CCR2 RFP+ and CCR2 knockout mice, intratracheal instillation of ODE, LPS, or peptidoglycan (PGN), and clodronate liposome administration to deplete monocytes.
  • Quantified inflammatory/fibrotic mediators using ELISA, characterized infiltrating lung cells via flow cytometry, and assessed lung histopathology and molecular markers.

Main Results:

  • ODE, LPS, and PGN induced recruitment of CCR2+ and CCR2- monocytes/macrophages, T cells, and NK cells.
  • CCR2 knockout mice showed no protection against LPS-induced lung injury; instead, neutrophils and chemokines increased.
  • Clodronate liposome treatment significantly reduced LPS-induced monocyte-macrophage infiltration, inflammatory cytokines (IL-6), matrix metalloproteinases, collagen, and protein modifications (citrullination, MAA).

Conclusions:

  • Environmental exposures induce diverse monocyte/macrophage subpopulations in the lungs.
  • Depleting peripheral monocytes is a promising strategy to reduce adverse lung consequences from LPS-enriched inhalant exposures.